Management
Implementing Leadership Change
Learning Team B: Rhona Bravo, Shameka Decuir, Tonya Gordon, and William Walton
LDR/531 Organizational Leadership
Lynette Grizelle
September 17, 2012
Gene One is a private biotech company, founded by Don Ruiz (CEO) eight years ago with four colleagues Michelle Houghton, Chief Financial Officer, Charles Jones, Marketing Officer, Teri Robertson, Chief Technology Officer, and Greg Thoman, Chief Human Resources Officer (Gene One Scenario, 2010). Gene One is an innovate company that entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. The discovery of this breakthrough technology greatly affects farmers and end consumers who provides solutions to both relative to their individual needs. For farmers, this breakthrough will stop the need to use pesticides, and consumers can to access homegrown organic products at affordable prices. Gene One grew up to $400 million in eight years, based on this gene technology. This level of growth within this short time is outstanding. At Gene One, the CEO, and his Board believe in 40% annual growth targets, Gene One has identified a business need to transition to a publically traded company within the next three years is going. The company needs IPO capital for new research and development, advertisement, and marketing if it is to remain successful. Gene One and the leadership team need to make a change from small private business status, to that of a publicly traded entity on Wall Street. A corporate decision is already made to pursue an initial public offering (IPO) to obtain the necessary capital to realize this growth. Under the direction of CEO Don Ruiz, the offered IPO is scheduled within 36 months (Gene One Scenario, 2010). In any organization regardless of how the size, change will present some of the biggest challenges to existing business philosophies and business practices.
Learning Team B: Rhona Bravo, Shameka Decuir, Tonya Gordon, and William Walton
LDR/531 Organizational Leadership
Lynette Grizelle
September 17, 2012
Gene One is a private biotech company, founded by Don Ruiz (CEO) eight years ago with four colleagues Michelle Houghton, Chief Financial Officer, Charles Jones, Marketing Officer, Teri Robertson, Chief Technology Officer, and Greg Thoman, Chief Human Resources Officer (Gene One Scenario, 2010). Gene One is an innovate company that entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. The discovery of this breakthrough technology greatly affects farmers and end consumers who provides solutions to both relative to their individual needs. For farmers, this breakthrough will stop the need to use pesticides, and consumers can to access homegrown organic products at affordable prices. Gene One grew up to $400 million in eight years, based on this gene technology. This level of growth within this short time is outstanding. At Gene One, the CEO, and his Board believe in 40% annual growth targets, Gene One has identified a business need to transition to a publically traded company within the next three years is going. The company needs IPO capital for new research and development, advertisement, and marketing if it is to remain successful. Gene One and the leadership team need to make a change from small private business status, to that of a publicly traded entity on Wall Street. A corporate decision is already made to pursue an initial public offering (IPO) to obtain the necessary capital to realize this growth. Under the direction of CEO Don Ruiz, the offered IPO is scheduled within 36 months (Gene One Scenario, 2010). In any organization regardless of how the size, change will present some of the biggest challenges to existing business philosophies and business practices.